PSE Product Makes “Highly” Tamper-Resistant Claim With 100% Out Of Reach

Westport Pharmaceuticals says a claim of being “highly” resistant to PSE-extraction distinguishes Zephrex-D from the competition, but the distinction alone is not adding up to market-share gains in the nonprescription nasal decongestant space.

More from United States

More from North America